Thyroid and Cardiovascular DiseaseAnne Rentoumis Cappola, Ari J. Wassner, Christina Ellervik et al.|Circulation|2019Cited by 123
HuR/Cx40 downregulation causes coronary microvascular dysfunction in type 2 diabetesRui Si, Ayako Makino, Jody Tori O. Cabrera et al.|JCI Insight|2021Cited by 23
eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetesLei Gao, Ayako Makino, Francisco J. Ramírez et al.|Diabetologia|2024Cited by 6
Pathophysiological role of NAMPT in endothelial functionFrancisco Ramirez, Ayako Makino, Jody Tori O. Cabrera et al.|Physiology|2023Cited by 1
Sex differences in the development of coronary microvascular diseases in type-2 diabetes: possible role of gap junction protein connexin-40Md Rahatullah Razan, Ayako Makino, Rui Si et al.|Physiology|2023Cited by 0